<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03079713</url>
  </required_header>
  <id_info>
    <org_study_id>16-600E</org_study_id>
    <nct_id>NCT03079713</nct_id>
  </id_info>
  <brief_title>Handheld Vibrator Versus Topical Eye Drops as Anesthesia for Intravitreal Injections</brief_title>
  <acronym>Eyebrator</acronym>
  <official_title>Comparison of Handheld Vibrator to Topical Eye Drops as Anesthesia for Intravitreal Injections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wills Eye</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mid Atlantic Retina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Wills Eye</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intravitreal injections are an efficient method of delivering therapeutic levels of
      medications to the posterior segment of the eye. Prior to receiving an injection, there are
      various methods to provide ocular anesthesia. Vibration may have an anti-nociceptive effect
      by directly decreasing the sensitivity of peripheral nociceptors or by reducing signal
      transmission from peripheral nociceptors to the brain with activation of vibratory sensation
      pathways. The purpose of this study is to evaluate the use of a handheld fingertip vibrator
      compared to topical eye drops for pain control while performing intravitreal eye injections.
      A secondary objective of the study is to measure corneal and conjunctiva sensitivity with and
      without activation of the vibrator to the lower lid using a Luneau Cochet-Bonnet
      aesthesiometer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 80 patients will be recruited for part 1 of the study. Participants will be
      randomized in a 1:1 ratio to a standard anesthetic group or standard anesthetic with
      vibration groups. All intravitreal drugs will be delivered via 30 gauge needles through the
      pars plana in the inferotemporal quadrant 3.5 to 4 mm posterior to the limbus. Once
      recruited, a single eye requiring injection for each enrolled patient will be randomized into
      1 of 2 groups: aesthesiometer measurement alone with sham vibration (vibrator will not be
      triggered) (Group 1) or handheld vibrator application and triggering followed by
      aesthesiometer measurement (Group 2). The vibrator will be applied to the lower eyelid while
      retracting it during standard intravitreal injection prepped with topical anesthetic
      (Proparacaine 1%) and Betadine. The main outcome measure of will be patient comfort, as
      measured by the patient using a standardized Wong-Baker FACES Pain Rating Scale.

      An additional 30 eyes of 30 healthy patients not requiring intravitreal injection will be
      recruited to determine the effect of vibrator application and triggering to the lower lid on
      corneal and conjunctival (inferotemporal quadrant) sensation as measured using an
      aesthesiometer. No topical anesthetic will be applied prior to esthesiometry measurements are
      taken with and without vibration triggering.

      All patient identifying information will be removed and patients will be identified with a
      random number. Data will be checked regularly by a data monitoring committee. Patient records
      will be reviewed and the following data will be collected: demographic data (age, gender,
      injected eye, reason for injection), best-corrected visual acuity, intraocular pressure, and
      complications/adverse events associated with intravitreal injections. Statistical analyses
      will include univariate comparisons between treatment groups using the Student t-test for
      continuous variables and Ï‡2 test or Fisher's exact test for categorical variables.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 12, 2017</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain assessment</measure>
    <time_frame>Immediately after intravitreal injection</time_frame>
    <description>Pain is assessed by Wong-Baker FACES Pain Rating Scale (score ranging from 0 to 10) immediately after the intravitreal injection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Corneal and conjunctival sensitivity</measure>
    <time_frame>immediately after application of a handheld vibrator</time_frame>
    <description>Corneal and conjunctival sensitivity, as measured using an aesthesiometer</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Pain Control During Intravitreal Injections</condition>
  <arm_group>
    <arm_group_label>Vibratory Anesthesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Following administration of topical anesthetic and betadine, wearable vibrator will be triggered prior to and during the intravitreal injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Injection.</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Following administration of topical anesthetic and betadine, wearable vibrator will be placed against the lower lid but NOT triggered prior to and during the intravitreal injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vibratory Anesthesia with Corneal/Conjunctival Sensation Test</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy patients not requiring intravitreal injection will be subjected to corneal and conjunctival aesthesiometry with and without the vibrator triggered while in contact with the lower eyelid of a single eye.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Handheld vibrator triggered during intravitreal injection for wet ARMD</intervention_name>
    <description>A vibratory device cleaned with alcohol swabs between each use will be attached to the injectors' finger, placed on the lower eyelid of the treatment eye, and triggered during intravitreal injection</description>
    <arm_group_label>Vibratory Anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Normal eye esthesiometry with and without vibration</intervention_name>
    <description>Healthy patients will undergo corneal and conjunctival esthesiometry with and without triggering of the wearable vibrator placed upon the lower lid of a single eye.</description>
    <arm_group_label>Vibratory Anesthesia with Corneal/Conjunctival Sensation Test</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Handheld vibrator not triggered during intravitreal injection for wet ARMD</intervention_name>
    <description>Control group undergoing standard intravitreal injection without triggering of the vibrator.</description>
    <arm_group_label>Standard Injection.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of neovascular age related macular degeneration requiring anti-VEGF
             intravitreal injection in the routine course of their care

        Exclusion Criteria:

          -  History of endophthalmitis, prior ocular surgery except cataract surgery, globe
             rupture, retinal detachment, neurotrophic keratopathy, a history of corneal epithelial
             basement membrane dystrophy, recent corneal abrasion or trauma, history of infectious
             keratitis, lower eyelid pathology, those with a previously documented hypersensitivity
             to ophthalmic 5% povidone-iodine solution (Betadine; Alcon Labs, Fort Worth, TX) or
             inability to grade pain using the pain scale, pregnant patients, institutionalized
             patients (nursing home residents, prisoners), those with a history of diabetes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mitchell Fineman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mid Atlantic Retina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>MidAtlantic Retina-Wills Eye Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Friedman SM, Margo CE. Topical gel vs subconjunctival lidocaine for intravitreous injection: a randomized clinical trial. Am J Ophthalmol. 2006 Nov;142(5):887-8.</citation>
    <PMID>17056383</PMID>
  </reference>
  <reference>
    <citation>Kaderli B, Avci R. Comparison of topical and subconjunctival anesthesia in intravitreal injection administrations. Eur J Ophthalmol. 2006 Sep-Oct;16(5):718-21.</citation>
    <PMID>17061223</PMID>
  </reference>
  <reference>
    <citation>Cintra LP, Lucena LR, Da Silva JA, Costa RA, Scott IU, Jorge R. Comparative study of analgesic effectiveness using three different anesthetic techniques for intravitreal injection of bevacizumab. Ophthalmic Surg Lasers Imaging. 2009 Jan-Feb;40(1):13-8.</citation>
    <PMID>19205490</PMID>
  </reference>
  <reference>
    <citation>KarabaÅŸ VL, Ã–zkan B, KoÃ§er Ã‡A, AltÄ±ntaÅŸ Ã–, Pirhan D, YÃ¼ksel N. Comparison of two anesthetic methods for intravitreal ozurdex injection. J Ophthalmol. 2015;2015:861535. doi: 10.1155/2015/861535. Epub 2015 Apr 9.</citation>
    <PMID>25949822</PMID>
  </reference>
  <reference>
    <citation>Ornek N, Apan A, Ornek K, GÃ¼nay F. Anesthetic effectiveness of topical levobupivacaine 0.75% versus topical proparacaine 0.5% for intravitreal injections. Saudi J Anaesth. 2014 Apr;8(2):198-201. doi: 10.4103/1658-354X.130713.</citation>
    <PMID>24843332</PMID>
  </reference>
  <reference>
    <citation>Lundeberg TC. Vibratory stimulation for the alleviation of chronic pain. Acta Physiol Scand Suppl. 1983;523:1-51.</citation>
    <PMID>6609524</PMID>
  </reference>
  <reference>
    <citation>Smith KC, Comite SL, Balasubramanian S, Carver A, Liu JF. Vibration anesthesia: a noninvasive method of reducing discomfort prior to dermatologic procedures. Dermatol Online J. 2004 Oct 15;10(2):1. Review.</citation>
    <PMID>15530291</PMID>
  </reference>
  <reference>
    <citation>Aminabadi NA, Farahani RM, Balayi Gajan E. The efficacy of distraction and counterstimulation in the reduction of pain reaction to intraoral injection by pediatric patients. J Contemp Dent Pract. 2008 Sep 1;9(6):33-40.</citation>
    <PMID>18784857</PMID>
  </reference>
  <reference>
    <citation>Bagherian A, Sheikhfathollahi M. Children's behavioral pain reactions during local anesthetic injection using cotton-roll vibration method compared with routine topical anesthesia: A randomized controlled trial. Dent Res J (Isfahan). 2016 May-Jun;13(3):272-7.</citation>
    <PMID>27274349</PMID>
  </reference>
  <reference>
    <citation>Nanitsos E, Vartuli R, Forte A, Dennison PJ, Peck CC. The effect of vibration on pain during local anaesthesia injections. Aust Dent J. 2009 Jun;54(2):94-100. doi: 10.1111/j.1834-7819.2009.01100.x.</citation>
    <PMID>19473149</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 8, 2017</study_first_submitted>
  <study_first_submitted_qc>March 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 14, 2017</study_first_posted>
  <last_update_submitted>March 26, 2018</last_update_submitted>
  <last_update_submitted_qc>March 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wills Eye</investigator_affiliation>
    <investigator_full_name>MidAtlantic Retina</investigator_full_name>
    <investigator_title>Dr Mitchell Fineman MD</investigator_title>
  </responsible_party>
  <keyword>pain</keyword>
  <keyword>anesthesia</keyword>
  <keyword>vibrator</keyword>
  <keyword>intravitreal</keyword>
  <keyword>injection</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Ophthalmic Solutions</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

